|Born||27 March 1969|
|Alma mater||University of Oslo|
|Occupation||medical scientist, research administrator and civil servant|
John-Arne Røttingen (born 27 March 1969) is a Norwegian medical scientist, research administrator and civil servant. He is the current Chief executive officer of the Research Council of Norway, and has been a special advisor to the World Health Organization (WHO).
Røttingen is from Bø, Telemark. He graduated as cand.med. in 1996 and dr.med. in 1999 from the University of Oslo, and then from the University of Oxford, and Harvard Kennedy School. He was a researcher at the University of Oslo and at the Harvard School of Public Health. His research interests have been epidemiology and global health.
Earlier in his career, Røttingen worked as executive director of infection control and environmental health at the Norwegian Institute of Public Health (NIPH). In this capacity, he also chaired the WHO's Consultative Expert Working Group on Research and Development from 2010 until 2012.
In January 2017, Røttingen served as interim CEO for the launch of Coalition for Epidemic Preparedness Innovations at the World Economic Forum in Davos. Since its inception in 2017, he has been also a member the Scientific Advisory Group of the WHO R&D Blueprint, a global strategy and preparedness plan that allows the rapid activation of research activities during epidemics, chaired by Jeremy Farrar.
From 2020, Røttingen also chaired the Executive Group and the International Steering Committee of the WHO' Solidarity trial to compare four untested treatments for hospitalized people with severe COVID-19 illness.
In early 2021, Røttingen was appointed by the G20 to the High Level Independent Panel (HLIP) on financing the global commons for pandemic preparedness and response, co-chaired by Ngozi Okonjo-Iweala, Tharman Shanmugaratnam and Lawrence Summers. That same year, he was also appointed to the Pandemic Preparedness Partnership (PPP), an expert group chaired by Patrick Vallance to advise the G7 presidency held by the government of Prime Minister Boris Johnson.
- Gavi, Member of the Board
- PATH, Member of the Board of Directors
- Alliance for Health Policy and Systems Research, Chair of the Board
|Wikiquote has quotations related to: John-Arne Røttingen|
- Hansen, Tor Ivar. "John-Arne Røttingen". In Bolstad, Erik (ed.). Store norske leksikon (in Norwegian). Oslo: Norsk nettleksikon. Retrieved 3 November 2018. CS1 maint: discouraged parameter (link)
- Betsy McKay (January 21, 2016), Health Threats Spur Vaccine Hunt Wall Street Journal.
- 65th Session of the World Health Assembly, 20 April 2012: Consultative Expert Working Group on Research and Development: Financing and Coordination World Health Organization (WHO).
- John Cohen (2 September 2016). "New vaccine coalition aims to ward off epidemics". Science. 353 (6303).
- Kate Kelland (January 18, 2017), Global coalition aims to outpace epidemics with new vaccines Reuters.
- R&D Blueprint Scientific Advisory Group members World Health Organization.
- Lauritsen, Eivind Nicolai (14 June 2016). "John-Arne Røttingen blir ny direktør for Forskningsrådet". forskning.no (in Norwegian). Retrieved 3 November 2018. CS1 maint: discouraged parameter (link)
- Aadland, Ingebjørg (14 June 2016). "John-Arne Røttingen blir Forskningsrådets nye direktør". forskningsradet.no (in Norwegian). Retrieved 3 November 2018. CS1 maint: discouraged parameter (link)
- Asher Mullard (April 14, 2020), An audience with John-Arne Røttingen Nature.
- The G20 establishes a High Level Independent Panel on financing the Global Commons for Pandemic Preparedness and Response Ministry of Economy and Finance, press release of January 27, 2021.
- New global partnership launched to fight future pandemics Government of the United Kingdom, press release of April 20, 2021.
- Members of the Board Gavi.
- Leadership PATH.
- John-Arne Røttingen Blavatnik School of Government, University of Oxford.
| Director of the Research Council of Norway